Irish Life Investment Managers’s Rigel Pharmaceuticals RIGL Stock Holding History

Irish Life Investment Managers’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$14.8K	Buy	+445	New	+$20.2K	﹤0.01%	1905

Other funds holding RIGL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Irish Life Investment Managers's RIGL Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in Rigel Pharmaceuticals (RIGL) in Q2 2013: 445 shares worth $14.8K. The stake represents ﹤0.01% of the portfolio and ranks #1905 among its holdings.

94 funds tracked by Wall St. Rank hold RIGL as of Q2 2013.

Irish Life Investment Managers held 445 shares of Rigel Pharmaceuticals worth $14.8K as of Q2 2013.
Rigel Pharmaceuticals was a new Irish Life Investment Managers position in Q2 2013.
Rigel Pharmaceuticals made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #1905 holding.
94 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.